acloproxalap   Click here for help

GtoPdb Ligand ID: 12097

Synonyms: Compound 5 [WO2020223685A1]
Compound class: Synthetic organic
Comment: We obtained the chemical structure for acloproxalap from the WHO's proposed INN list 127 (21 July 2022). In this document it was described as an anti-inflammatory. Acloproxalap is an analogue of reproxalap. Like its predecessor, acloproxalap was designed as a molecular trap for pro-inflammatory Reactive Aldehyde Species (RASP) molecules that are produced by metabolic and inflammatory processes, to treat diseases in which aldehyde toxicity is implicated in the pathogenesis [1]. We predict that acloproxalap is the INN for the clinical lead known as ADX-629.
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 3
Hydrogen bond donors 2
Rotatable bonds 1
Topological polar surface area 59.14
Molecular weight 202.11
XLogP 1.65
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES Nc1cc2ccccc2nc1C(O)(C)C
Isomeric SMILES Nc1c(nc2ccccc2c1)C(C)(C)O
InChI InChI=1S/C12H14N2O/c1-12(2,15)11-9(13)7-8-5-3-4-6-10(8)14-11/h3-7,15H,13H2,1-2H3
InChI Key NOFRQDXKZDAYGB-UHFFFAOYSA-N
References
1. Machatha SG, Montgomery C, Krausert S, Loughrey JJ, McLachlan HR, Sneddon G. (2020)
Polymorphic compounds and uses thereof.
Patent number: WO2020223685A1. Assignee: Aldeyra Therapeutics, Inc.. Priority date: 02/05/2019. Publication date: 05/11/2020.